Over 260 exhibitors and a world-class scientific program will spotlight the latest technologies driving personalized medicine, advanced analytics, and digital transformation in the lab.
Oncology drug discovery faces one of the highest attrition rates for drug candidates in the
development pipeline, largely due to efficacy issues. More relevant clinical models, ones that better reflect cancer heterogeneity and disease progression,
could address this problem.
Explore how a needs-driven approach to electronic laboratory notebook selection can improve data integrity, reproducibility, and scientific continuity.